ArticleCardiovascular drugs and therapy2020
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report.
Article in Cardiovascular drugs and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.European journal of internal medicine · 2021Pooled it
- [Clinical features of pericarditis in patients with SARS-CoV-2].Revista medica del Instituto Mexicano del Seguro Social · 2023Observational
- Review
- Current evidence on the use of anakinra in COVID-19.International immunopharmacology · 2022Review
- A Systematic Review of COVID-19 and Pericarditis.Cureus · 2022Review
- Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report.The open respiratory medicine journal · 2022Article
- Recurrent Pericarditis After Covid-19.Reumatologia clinica · 2021Article
- Pericardial Diseases in COVID19: a Contemporary Review.Current cardiology reports · 2021Review
- Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.Pharmaceuticals (Basel, Switzerland) · 2021Review
- Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.BMJ case reports · 2021Article
- CT findings in a patient with Coronavirus Disease-19-associated acute pericarditis.BJR case reports · 2021Article
- Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021Review
- J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?PloS one · 2021Article
- Recurrent pericarditis after Covid-19.Reumatologia clinicaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.